CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.
about
Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug DevelopmentThe Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.Histone modifications are associated with Δ9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responsesSelective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity.Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.Rapid vasodilation to raloxifene: role of oestrogen receptors and off-target effects.
P2860
CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.
@en
CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.
@nl
type
label
CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.
@en
CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.
@nl
prefLabel
CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.
@en
CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.
@nl
P2093
P2860
P1476
CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.
@en
P2093
Aleksandra K Greer
Anna Radominska-Pandya
Benjamin M Ford
Centdrika R Dates
FeAna FrancisDevaraj
Lirit N Franks
Paul L Prather
Stacie M Bratton
P2860
P304
P356
10.1016/J.BBRC.2013.10.057
P407
P577
2013-10-19T00:00:00Z